Reta

Reta (LY-3437943) is a potent synthetic peptide engineered for advanced biochemical and metabolic research. Composed of 39 amino acids and exhibiting an exceptional purity of ~99.3%, this triple receptor agonist is specifically designed to activate GLP-1, GIP, and glucagon receptors—key regulators in energy balance, fat metabolism, and glucose control.

As a powerful appetite suppressant and fat-burning research agent, Reta holds strong relevance in preclinical studies targeting weight management, energy expenditure, and metabolic disorders. It represents the next-generation evolution of dual-agonist models by offering synergistic benefits across three key pathways.

Each batch is verified by Janoshik Independent Peptide Analytics and ships with a full Certificate of Analysis (COA), including HPLC and mass spectrometry data for full transparency and traceability.

Key Specifications

• Purity: ~99.3% (HPLC tested – COA available)

• Molecular Formula / Weight: C221H342N46O68 / 4,731.33 Da

• Amino Acid Sequence: Fully documented in COA

• Testing Lab: Janoshik Independent Peptide Analytics

• Analytical Methods: HPLC and Mass Spectrometry

• Form: Lyophilized Powder

• Storage: Refrigerated; protect from light and moisture

Research Applications & Benefits

• Triple agonist profile enables comprehensive exploration of glucose regulation, satiety, and lipid metabolism.

• Ideal for studying mechanisms involved in obesity, type 2 diabetes, and energy homeostasis.

• Provides enhanced efficacy over dual-agonist models through multi-pathway activation.

• Backed by independent verification and transparent analytics.

For research use only. Not for human or veterinary use.